Spero Therapeutics
SPRO
#9057
Rank
S$95.47 M
Marketcap
$1.77
Share price
-0.75%
Change (1 day)
17.02%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of June 2024 : S$85.01 Million

According to Spero Therapeutics's latest financial reports the company has S$85.01 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.10 B-31.08%
2022-12-31S$0.14 B-26.1%
2021-12-31S$0.19 B17.89%
2020-12-31S$0.16 B51.78%
2019-12-31S$0.11 B-29.87%
2018-12-31S$0.15 B35.09%
2017-12-31S$0.11 B682.02%
2016-12-31S$14.92 M85.45%
2015-12-31S$8.05 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$48.94 M-42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.33 B 21,468.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.38 B 2,709.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada